Latest Breaking News On - Ytomed therapeutics kurs - Page 1 : comparemela.com

29.01.2024 - The Company now has exclusive rights to a Malaysia, US and China patentSINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) - CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on . Seite 1

Peter chooCytomed therapeutics limitedCytomed or companyProperty corporation of malaysiaExchange commissionMed therapeutics limitedIntellectual property corporationDeltat cellsTumoricidal activityLicense agreementCytomed therapeutics chartYtomed therapeutics kursYtomed therapeutics aktie